Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
September 9, 2014
High molecular weight hyaluronic acid increases the differentiation potential of the murine chondrocytic ATDC5 cell line
Eiichi Sato, Takashi Ando, Jiro Ichikawa, et al.
Plos One
|
February 10, 2025
Effects of outdoor play on body composition and physical performance in children: the Yamanashi Adjunct study of the Japan Environment and Children's Study
Masanori Wako, Taro Fujimaki, Jiro Ichikawa, et al.
Bone
|
October 18, 2015
Thrombin induced by the extrinsic pathway and PAR-1 regulated inflammation at the site of fracture repair
Nobutaka Sato, Jiro Ichikawa, Masanori Wako, et al.
Frontiers in Oncology
|
November 26, 2024
Case report: a rare clinical presentation of a difficult diagnosis of dedifferentiated liposarcoma showing leiomyosarcoma phenotype in the ileocecal region
Tomonori Kawasaki, Tomoaki Tashima, Kojiro Onohara, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 2, 2020
Role of Platelet C-Type Lectin-Like Receptor 2 in Promoting Lung Metastasis in Osteosarcoma
Jiro Ichikawa, Takashi Ando, Tomonori Kawasaki, et al.
International Journal of Cancer
|
August 18, 2010
T cell recognition of HLA-A2 restricted tumor antigens is impaired by the oncogene HER2
Kousaku Mimura, Takashi Ando, Isabel Poschke, et al.
Oncogenesis
|
March 13, 2021
EHF suppresses cancer progression by inhibiting ETS1-mediated ZEB expression
Kaname Sakamoto, Kaori Endo, Kei Sakamoto, et al.
Cancer
|
September 29, 2011
Thrombin induces osteosarcoma growth, a function inhibited by low molecular weight heparin in vitro and in vivo: procoagulant nature of osteosarcoma
Jiro Ichikawa, Heather A Cole, Robert A Magnussen, et al.
Oncogene
|
October 21, 2025
Meflin is a druggable target using antibody-drug conjugates in progressive osteosarcoma
Nobutoshi Esaki, Tomoka Sakoda, Ryota Ando, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
September 9, 2014
High molecular weight hyaluronic acid increases the differentiation potential of the murine chondrocytic ATDC5 cell line
Eiichi Sato, Takashi Ando, Jiro Ichikawa, et al.
Plos One
|
February 10, 2025
Effects of outdoor play on body composition and physical performance in children: the Yamanashi Adjunct study of the Japan Environment and Children's Study
Masanori Wako, Taro Fujimaki, Jiro Ichikawa, et al.
Bone
|
October 18, 2015
Thrombin induced by the extrinsic pathway and PAR-1 regulated inflammation at the site of fracture repair
Nobutaka Sato, Jiro Ichikawa, Masanori Wako, et al.
Frontiers in Oncology
|
November 26, 2024
Case report: a rare clinical presentation of a difficult diagnosis of dedifferentiated liposarcoma showing leiomyosarcoma phenotype in the ileocecal region
Tomonori Kawasaki, Tomoaki Tashima, Kojiro Onohara, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 2, 2020
Role of Platelet C-Type Lectin-Like Receptor 2 in Promoting Lung Metastasis in Osteosarcoma
Jiro Ichikawa, Takashi Ando, Tomonori Kawasaki, et al.
International Journal of Cancer
|
August 18, 2010
T cell recognition of HLA-A2 restricted tumor antigens is impaired by the oncogene HER2
Kousaku Mimura, Takashi Ando, Isabel Poschke, et al.
Oncogenesis
|
March 13, 2021
EHF suppresses cancer progression by inhibiting ETS1-mediated ZEB expression
Kaname Sakamoto, Kaori Endo, Kei Sakamoto, et al.
Cancer
|
September 29, 2011
Thrombin induces osteosarcoma growth, a function inhibited by low molecular weight heparin in vitro and in vivo: procoagulant nature of osteosarcoma
Jiro Ichikawa, Heather A Cole, Robert A Magnussen, et al.
Oncogene
|
October 21, 2025
Meflin is a druggable target using antibody-drug conjugates in progressive osteosarcoma
Nobutoshi Esaki, Tomoka Sakoda, Ryota Ando, et al.
Page
of 8